August 10, 2015
3 min read
Save

Weight cycling does not increase cancer risk

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Weight cycling does not appear associated with elevated cancer risk, according to an analysis of data from a large prospective cohort.

Nearly half of all U.S. adults have tried to lose weight, but most are unable to maintain their weight loss. This recurring cycle of intentional weight loss followed by weight regain is known as weight cycling or “yo-yo dieting.”

“Although both weight and weight gain are known to increase risk of cancer, whether weight cycling is associated with cancer risk, independent of body weight, is largely unknown,” Victoria L. Stevens, PhD, of the Epidemiology Research Program for the American Cancer Society, and colleagues wrote. “Because many people try to lose weight, understanding whether weight cycling is associated with cancer risk has important public health implications.”    

 

Large prospective U.S. cohort

Stevens and colleagues conducted the first large, comprehensive study to assess the association between weight cycling and overall and site-specific cancer risk. They analyzed data from 62,792 men and 69,520 women who participated in the American Cancer Society Cancer Prevention Study II (CPS-II) Nutrition Cohort.

The researchers defined weight cycling as self-reported intentional weight loss of 10 pounds or more that were later regained. The investigators assessed incidence of all cancer among study participants between 1992 and 2009. They also assessed incidence of 15 specific cancer types, including prostate, colon, rectal, pancreatic, renal, esophageal, liver, stomach and lung cancers, melanoma, non-Hodgkin’s lymphoma and myeloma.

Overall, 15,333 men and 9,984 women developed cancer during the 17-year study period.

Results for models that adjusted for BMI and other covariates showed no association between weight cycling and overall cancer risk among women (HR = 0.96; 95% CI, 0.86-1.08 for ≥ 20 cycles vs. no weight cycles) or men (HR = 0.96; 95% CI, 0.83-1.11 for ≥ 20 cycles vs. no weight cycles). The researchers observed no associations between weight cycling and any specific cancer type analyzed.

“For the millions of Americans struggling to lose weight, the last thing they need to worry about is that if it comes back, they might raise their risk of cancer,” Stevens said in a press release. “This study, to our knowledge the largest and most comprehensive to date on the issue, should be reassuring. Our findings suggest that overweight and obese individuals should not let fears about their ability to maintain weight loss keep them from trying to lose weight in the first place.”

 

Most recent articles on diet and health

People who are trying to lose weight should be encouraged to do so even though they may regain it given the extensive health benefits of maintaining a healthy weight, Stevens and colleagues wrote.

HemOnc Today and Healio.com present five “fast facts” to consider with regard to diet and health:

1. Vegetarian diets are linked to a lower incidence of colorectal cancer.

Researchers found that vegetarian dietary patterns in a large North American cohort, particularly the pescovegetarian dietary pattern, were associated with lower risk of all colorectal cancer, as well as colon cancer specifically. Of the 77,659 participants included in the study, the researchers identified 490 colorectal cancer cases (380 colon cancers; 110 rectal cancers) during a mean follow-up period of 7.3 years. Read more

2. Mediterranean diet lowers platelet, white blood cell counts.

In a large cohort of healthy men and women, researchers identified an inverse association between adherence to the Mediterranean diet and both platelet (P < .0001) and white blood cell counts (P = .008). Study participants who reported increased adherence to the Mediterranean diet were least likely to be among the highest platelet count group (OR = 0.5; 95% CI, 0.31-0.8) and more likely to be in the lowest white blood cell count group (OR = 1.41; 95% CI, 1.07-1.86). Read more      

3. Adherence to dietary guideline lowered risk for liver disease mortality, hepatocellular carcinoma.

Older participants who followed strict dietary recommendations demonstrated a decreased risk for chronic liver disease mortality and hepatocellular carcinoma. Greens, beans and seafood in the Healthy Eating Index-2010 and the ratio of alcohol and monounsaturated/saturated fats in the alternate Mediterranean Diet Score were associated with reduced risks for hepatocellular carcinoma and chronic liver disease mortality. In addition, whole grains, dairy and nuts in the alternate Mediterranean Diet Score showed an inverse association with chronic liver disease mortality, whereas legumes in the alternate Mediterranean Diet Score, empty calories in the Healthy Eating Index-2010, and vegetables in both indices were inversely associated with hepatocellular carcinoma incidence. Read more

4. High-protein diet during middle age may increase risk for diabetes, cancer, mortality. According to a study published in Cell Metabolism involving 6,381 adults aged at least 50 years, a diet high or moderate in animal-derived protein may increase the risk for diabetes, cancer and all-cause mortality. However, high protein intake may be beneficial for older adults, as protein controls insulin-like growth factor I, levels of which dramatically decrease after age 65 years and can lead to frailty and muscle loss. Read more

5. Diet, exercise interventions decrease functional decline among cancer survivors.

According to results of the Reach out to Enhance Wellness — or RENEW — trial, a diet and exercise intervention appeared associated with a significant reduction in functional decline among older, overweight long-term cancer survivors. Read moreby Jennifer Southall

Disclosure: Stevens and colleagues report no relevant financial disclosures.